![PDF] Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. | Semantic Scholar PDF] Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/48efca2c1c5afc8e47187ee9e2fbfeb4ca7352bb/2-Figure1-1.png)
PDF] Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. | Semantic Scholar
![Evaluation of the relationship between polymorphisms in CYP2C19 and the pharmacokinetics of omeprazole, pantoprazole and rabeprazole | Pharmacogenomics Evaluation of the relationship between polymorphisms in CYP2C19 and the pharmacokinetics of omeprazole, pantoprazole and rabeprazole | Pharmacogenomics](https://www.futuremedicine.com/cms/10.2217/pgs.14.141/asset/images/medium/figure1.gif)
Evaluation of the relationship between polymorphisms in CYP2C19 and the pharmacokinetics of omeprazole, pantoprazole and rabeprazole | Pharmacogenomics
![COMPARISON OF INHIBITORY EFFECTS OF THE PROTON PUMP-INHIBITING DRUGS OMEPRAZOLE, ESOMEPRAZOLE, LANSOPRAZOLE, PANTOPRAZOLE, AND RABEPRAZOLE ON HUMAN CYTOCHROME P450 ACTIVITIES | Drug Metabolism & Disposition COMPARISON OF INHIBITORY EFFECTS OF THE PROTON PUMP-INHIBITING DRUGS OMEPRAZOLE, ESOMEPRAZOLE, LANSOPRAZOLE, PANTOPRAZOLE, AND RABEPRAZOLE ON HUMAN CYTOCHROME P450 ACTIVITIES | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/32/8/821/F1.large.jpg)
COMPARISON OF INHIBITORY EFFECTS OF THE PROTON PUMP-INHIBITING DRUGS OMEPRAZOLE, ESOMEPRAZOLE, LANSOPRAZOLE, PANTOPRAZOLE, AND RABEPRAZOLE ON HUMAN CYTOCHROME P450 ACTIVITIES | Drug Metabolism & Disposition
![Mean percentage of time over the nocturnal hours on day 1 that gastric... | Download Scientific Diagram Mean percentage of time over the nocturnal hours on day 1 that gastric... | Download Scientific Diagram](https://www.researchgate.net/publication/44614327/figure/fig3/AS:394343627149320@1471030255639/Mean-percentage-of-time-over-the-nocturnal-hours-on-day-1-that-gastric-acid-output-is.png)
Mean percentage of time over the nocturnal hours on day 1 that gastric... | Download Scientific Diagram
Pantoprazole, Rabeprazole, Esomeprazole & Omeprazo - Rabeprazole 40mg & Domperidone 30mg SR Cap Manufacturer from Jaipur
![The Proton Pump Inhibitor, Omeprazole, but Not Lansoprazole or Pantoprazole, Is a Metabolism-Dependent Inhibitor of CYP2C19: Implications for Coadministration with Clopidogrel | Drug Metabolism & Disposition The Proton Pump Inhibitor, Omeprazole, but Not Lansoprazole or Pantoprazole, Is a Metabolism-Dependent Inhibitor of CYP2C19: Implications for Coadministration with Clopidogrel | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/content/dmd/39/11/2020/F1.large.jpg)
The Proton Pump Inhibitor, Omeprazole, but Not Lansoprazole or Pantoprazole, Is a Metabolism-Dependent Inhibitor of CYP2C19: Implications for Coadministration with Clopidogrel | Drug Metabolism & Disposition
![PDF) Comparative Efficacy of Rabeprazole and Pantoprazole in the Control of Nocturnal Acid Output and Intragastric Acidity PDF) Comparative Efficacy of Rabeprazole and Pantoprazole in the Control of Nocturnal Acid Output and Intragastric Acidity](https://i1.rgstatic.net/publication/44614327_Comparative_Efficacy_of_Rabeprazole_and_Pantoprazole_in_the_Control_of_Nocturnal_Acid_Output_and_Intragastric_Acidity/links/0912f50204dfce983e000000/largepreview.png)
PDF) Comparative Efficacy of Rabeprazole and Pantoprazole in the Control of Nocturnal Acid Output and Intragastric Acidity
![A Review of the Management of Gastric Acid-Related Diseases: Focus on Rabeprazole - Motoyasu Kusano, Shikou Kuribayashi, Osamu Kawamura, Yasuyuki Shimoyama, Hiroko Hosaka, Atsuto Nagoshi, Hiroaki Zai, Masatomo Mori, 2011 A Review of the Management of Gastric Acid-Related Diseases: Focus on Rabeprazole - Motoyasu Kusano, Shikou Kuribayashi, Osamu Kawamura, Yasuyuki Shimoyama, Hiroko Hosaka, Atsuto Nagoshi, Hiroaki Zai, Masatomo Mori, 2011](https://journals.sagepub.com/cms/10.4137/CGast.S5133/asset/images/large/10.4137_cgast.s5133-fig1.jpeg)